Yvonne Briggs
Investor Relations (LHA)
Replay available
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Q2 2024 earnings conference call, held 2024-08-22. Replay captured from the company's public earnings webcast.

Investor Relations (LHA)
Acting Chief Executive Officer
Head of Regulatory and Clinical Affairs
Chief Technology Officer
Chief Financial Officer
Analyst, Ascendant Capital
Watch the replay and follow the connected company analysis, news, and investor updates for Endra Life Sciences Inc..
WEBVTT 00:00:00.069 -- 00:00:05.571 Good afternoon and welcome to the Endura Life Sciences second quarter 2024 00:00:05.571 -- 00:00:10.634 financial results conference call. All participants will be in listen only 00:00:10.634 -- 00:00:15.716 mode. Should you need assistance, please signal a conference specialist by 00:00:15.716 -- 00:00:19.337 pressing the star key followed by zero. 00:00:19.337 -- 00:00:23.699 After today's presentation, there will be an opportunity to ask questions. 00:00:23.699 -- 00:00:28.683 To ask a question, you may press star then one on your telephone keypad. 00:00:28.683 -- 00:00:33.005 To withdraw your question, please press star, then two. 00:00:33.005 -- 00:00:37.008 Please note, this event is being recorded. 00:00:37.008 -- 00:00:39.749 I would now like to turn the conference over to Yvonne Briggs. 00:00:39.749 -- 00:00:40.449 Please go ahead. 00:00:40.449 -- 00:00:45.132 Yvonne Briggs Thank you, Operator. This is Yvonne Briggs with LHA. 00:00:45.132 -- 00:00:49.975 Good afternoon and welcome to Endra Life Sciences' second quarter 2024 Business Update 00:00:49.975 -- 00:00:54.577 and Financial Results conference call. Earlier today, Endra issued a press release on 00:00:54.577 -- 00:00:59.212 this topic, which is available in the Investors section of Endra's website. 00:00:59.212 -- 00:01:04.356 Before we begin, please note that today's discussion will include forward-looking statements, 00:01:04.356 -- 00:01:09.560 all statements by management other than statements of historical facts, including statements 00:01:09.560 -- 00:01:14.644 regarding the company's strategies, financial condition, operations, costs, plans, 00:01:14.644 -- 00:01:20.749 and objectives, as well as anticipated results of development and commercialization effort...